Workflow
功能保健品
icon
Search documents
研报掘金丨华西证券:维持伊利股份“买入”评级,强化长期投资价值预期
Ge Long Hui· 2025-11-24 06:09
Core Insights - Yili Group held an investor day themed "Focus on Growth, Value Innovation," outlining its 14th Five-Year Plan and announcing a shareholder return plan for 2025-2027, committing to an annual dividend payout ratio of no less than 75% and a per-share dividend of at least 1.22 yuan (including tax) [1] Group 1: Strategic Direction - The company aims to drive structural growth through a dual-track strategy of "stable growth from the core business + high elasticity from new businesses," solidifying its liquid milk base [1] - The adult nutrition segment and domestic substitution in dairy deep processing are identified as core growth drivers, with a five-year revenue target of 10 billion yuan [1] Group 2: Product Development - The product matrix will expand from adult milk powder to specialized medical foods and functional health products, prioritizing probiotics and protein supplements [1] - The company plans to systematically develop dairy fat and lactose deep processing categories, aiming for domestic substitution of key raw materials and entering B-end markets such as baking, tea beverages, and health products [1] Group 3: Growth Targets - Yili Group has set a target for revenue growth to exceed GDP and industry growth rates over the next five years [1] - The company maintains a "Buy" rating, reinforcing its long-term investment value expectations [1]
伊利股份(600887):“十五五”方向确定,当前最佳稳健配置品种
HUAXI Securities· 2025-11-23 14:56
Investment Rating - The investment rating for the company is "Buy" [1] Core Insights - The company has outlined its strategic direction for the "14th Five-Year Plan" and committed to a shareholder return plan for 2025-2027, promising a dividend payout ratio of no less than 75% and a minimum dividend of 1.22 yuan per share (including tax) [2] - The company is transitioning from a phase of "quantity increase" to "quality improvement" in the dairy industry, focusing on structural growth driven by a dual-engine strategy of stable growth in liquid milk and high elasticity in new business segments [3] - The company aims to achieve revenue growth exceeding GDP and industry growth rates over the next five years [3] Summary by Sections Business Strategy - The company is implementing a dual-track strategy to drive structural growth, focusing on stabilizing its liquid milk base while expanding into high-value segments such as adult nutrition products and deep processing of dairy [3] - The company plans to achieve a revenue target of 10 billion yuan from domestic substitutes for key raw materials over the next five years [3] International Expansion - The company is enhancing its global presence through three international business units, focusing on Southeast Asia, Australia, and New Zealand [4] - It has established a strong foothold in the Southeast Asian market, with significant growth in its ice cream business and a leading position in Indonesia [4] - The company aims to shift its international strategy from mere product export to a dual cycle of "resources + market" [4] Financial Performance and Forecast - The company has maintained its revenue forecasts for 2025-2027 at 119 billion, 122 billion, and 125 billion yuan, respectively, while adjusting its net profit forecasts to 110 billion, 116 billion, and 124 billion yuan [6] - The earnings per share (EPS) estimates have been revised to 1.74, 1.84, and 1.96 yuan for the same period [6] - The projected P/E ratios for 2025, 2026, and 2027 are 17, 16, and 15 times, respectively, supporting the "Buy" rating [6] Dividend Policy - The company has committed to a shareholder return plan that includes a dividend payout ratio of at least 75% and a minimum dividend of 1.22 yuan per share, which corresponds to a current dividend yield of approximately 5% [5] - This commitment is expected to enhance profit certainty and reduce valuation volatility risks [5]